Skip to content

David D. Aguilar

3 papers in the library · publishing 2014-2022

Papers

Sort Most recent Most cited

Subcortical control of the default mode network: Role of the basal forebrain and implications for neuropsychiatric disorders

Brain Research Bulletin May 1, 2022 David D. Aguilar, J. McNally

The precise interplay between large-scale functional neural systems throughout the brain is essential for performance of cognitive processes. In this review we focus on the default mode network (DMN), one such functional network that is active during periods of quiet wakefulness and believed to be involved in introspection and planning. Abnormalities in DMN functional connectivity and...

Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility.

The International Journal of Neuropsychopharmacology April 1, 2018 David D. Aguilar, Andrea Giuffrida, Daniel J Lodge

Epidemiological studies recognize cannabis intake as a risk factor for schizophrenia, yet the majority of adolescents who use marijuana do not develop psychosis. Similarly, the abuse of synthetic cannabinoids poses a risk for psychosis. For these reasons, it is imperative to understand the effects of adolescent cannabinoid exposure in susceptible individuals. We recently developed a novel...

Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.

The International Journal of Neuropsychopharmacology October 31, 2014 David D. Aguilar, Li Chen, Daniel J Lodge

Schizophrenia is a debilitating disorder that affects 1% of the US population. While the exogenous administration of cannabinoids such as tetrahydrocannabinol is reported to exacerbate psychosis in schizophrenia patients, augmenting the levels of endogenous cannabinoids has gained attention as a possible alternative therapy to schizophrenia due to clinical and preclinical observations. Thus,...

DOI: 10.1093/ijnp/pyu035 (opens in new tab) Full text (opens in new tab) Cannabinoids Hippocampus Phencyclidine Schizophrenia +1